You just read:

Tris Pharma Announces the Launch of DYANAVEL™ XR (amphetamine) Extended-release Oral Suspension, CII for the Treatment of Children with ADHD

News provided by

Tris Pharma, Inc.

Apr 19, 2016, 08:00 ET